Concepedia

Christophe Antczak

CA

38

Publications

1.8K

Citations

23

H-Index

2001

Active since

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Novartis (United States)

Cornell University

Novartis Institutes for BioMedical Research

Novartis (Switzerland)

Christophe Antczak is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, natural sciences, and cell biology.

ORCID

Top concepts

Publications per year

2001–2020

38

Publications

38

Tumor Targeting with Antibody-Functionalized, Radiolabeled Carbon Nanotubes

Michael R. McDevitt, Debjit Chattopadhyay, Barry J. Kappel et al. · Journal of Nuclear Medicine · 2007 · 452 citations · Full text

<scp>TMEM</scp> 41B is a novel regulator of autophagy and lipid mobilization

Francesca Moretti, Phil Bergman, Stacie E. Dodgson et al. · EMBO Reports · 2018 · 171 citations · Full text

, , +9

Combining integrated genomics and functional genomics to dissect the biology of a cancer‐associated, aberrant transcription factor, the <scp>ASPSCR1–TFE3</scp> fusion oncoprotein

Rachel Kobos, Makoto Nagai, Masumi Tsuda et al. · The Journal of Pathology · 2013 · 75 citations · Full text

, , +18

Cell viability assessment: toward content-rich platforms

Christina N. Ramirez, Christophe Antczak, Hakim Djaballah · Expert Opinion on Drug Discovery · 2010 · 69 citations · Full text

Synthesis of Antiproliferative <i>Cephalotaxus</i> Esters and Their Evaluation against Several Human Hematopoietic and Solid Tumor Cell Lines: Uncovering Differential Susceptibilities to Multidrug Resistance

Joseph D. Eckelbarger, Jeremy T. Wilmot, Matthew T. Epperson et al. · Chemistry - A European Journal · 2008 · 67 citations · Full text

Rows per page

1–5 of 38